Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Daiichi-Sankyo/Elil Lilly and Company
- Patient selection committee - Axon Therapies
- patient selection committee - Corvia Medical